AYA Stock Overview
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Artrya Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.31 |
| 52 Week High | AU$0.42 |
| 52 Week Low | AU$0.16 |
| Beta | 0.69 |
| 1 Month Change | 14.81% |
| 3 Month Change | 40.91% |
| 1 Year Change | 14.81% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -79.67% |
Recent News & Updates
Shareholder Returns
| AYA | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | 0% | 5.9% | 0.03% |
| 1Y | 14.8% | 63.1% | 4.2% |
Return vs Industry: AYA underperformed the Australian Healthcare Services industry which returned 61.8% over the past year.
Return vs Market: AYA exceeded the Australian Market which returned 6% over the past year.
Price Volatility
| AYA volatility | |
|---|---|
| AYA Average Weekly Movement | 16.3% |
| Healthcare Services Industry Average Movement | 8.0% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: AYA's share price has been volatile over the past 3 months.
Volatility Over Time: AYA's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Mat Regan | www.artrya.com |
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
Artrya Limited Fundamentals Summary
| AYA fundamental statistics | |
|---|---|
| Market cap | AU$24.40m |
| Earnings (TTM) | -AU$11.56m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.1x
P/E RatioIs AYA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AYA income statement (TTM) | |
|---|---|
| Revenue | AU$0 |
| Cost of Revenue | AU$9.48m |
| Gross Profit | -AU$9.48m |
| Other Expenses | AU$2.08m |
| Earnings | -AU$11.56m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did AYA perform over the long term?
See historical performance and comparison